You are acting as an adversarial independent reviewer before manuscript drafting. Do not assume the authors' interpretation is correct. Verify claims against code, frozen artifacts, data provenance and results. Seek alternative explanations, leakage, circularity, endpoint-definition problems, statistical weaknesses, truth-adjudication weaknesses and overclaiming.

Answer in detail:

1. Is the prospective design genuinely prospective after the V4.1 freeze?

2. Is there evidence of post-selection tuning affecting M60?

3. Are the M60 cases sufficiently independent from development cases and reference material?

4. Is challenge-case selection defensible or does it create hidden selection bias?

5. Is the truth protocol independent enough from the prediction systems?

6. Could shared reference resources create circularity?

7. Is treating 41/60 cases as truth-evaluable defensible?

8. Does having 19/60 uncertain cases materially weaken the main claim?

9. Does having zero resolved rpoB negatives invalidate any proposed rpoB conclusions?

10. Is overall 33/41 pooled accuracy meaningful across tetA and rpoB?

11. Should results primarily be reported per endpoint instead?

12. Is comparison with the endpoint-specific specialist tools fair?

13. Can 33/41 vs 34/41 be described in any stronger way than observed similarity?

14. Is "same observed accuracy with 67.7% fewer follow-up analyses" defensible?

15. Are we accidentally implying statistical equivalence?

16. Is follow-up action count a meaningful efficiency measure?

17. How should wall-clock runtime be presented?

18. What does the Sol ablation truly establish?

19. Does 54/60 planner divergence + 60/60 critic divergence + 0/60 endpoint divergence support the proposed architecture-level interpretation?

20. Could the validator be masking useful LLM differences?

21. Could the registered toolbox be insufficiently discriminating?

22. Does the mechanistic 8-error analysis support its stated causal interpretation?

23. For each of the 8 errors, is the assigned root cause justified by actual evidence?

24. Could a different action with the EXISTING toolbox have rescued any error?

25. Are any errors instead caused by endpoint/truth-definition mismatch?

26. Are the statistical methods adequate?

27. What additional analyses can be performed on EXISTING frozen data without compromising the primary study?

28. What analysis would be merely post-hoc hypothesis generation?

29. What statements belong in the abstract?

30. What statements must be removed or softened?

31. What is the strongest defensible central claim?

32. What is the strongest defensible secondary claim?

33. What are the three most serious reviewer objections?

34. What additional experiment, if any, would most improve the paper?

35. Is an additional fresh external benchmark required before publication?

36. Would independent human truth adjudication materially strengthen the study?

37. Does this work demonstrate an advantage of agentic AI, or primarily characterize when agentic reasoning becomes redundant?

38. Is the negative accuracy result scientifically interesting enough, given the efficiency/model-invariance findings?

39. What journal audience is this evidence strongest for: bioinformatics methods, AI-for-science, microbial genomics, or software/methodology?

40. Give a final assessment:

    A. claims well-supported; manuscript drafting can begin
    B. generally defensible but specific analyses are needed first
    C. major methodological weakness must be fixed before drafting
    D. primary claim not supported

Do not choose based on novelty or enthusiasm.
Choose based on evidence.
